Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036591 | SCV000060246 | likely benign | not specified | 2012-01-06 | criteria provided, single submitter | clinical testing | Arg141Arg in exon 10 of TNNT2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. Arg141Arg in exon 10 of TNNT2 (allele freque ncy = n/a) |
Gene |
RCV001719732 | SCV000722610 | likely benign | not provided | 2019-10-22 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000768723 | SCV000900093 | likely benign | Cardiomyopathy | 2022-08-02 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000874833 | SCV001017065 | benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2023-12-31 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000768723 | SCV001355069 | likely benign | Cardiomyopathy | 2018-11-18 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000874833 | SCV002810848 | benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2021-12-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003298062 | SCV003988657 | likely benign | Cardiovascular phenotype | 2023-04-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV003450706 | SCV004181371 | likely benign | Dilated cardiomyopathy 1D | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450707 | SCV004181372 | likely benign | Cardiomyopathy, familial restrictive, 3 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450705 | SCV004181374 | likely benign | Hypertrophic cardiomyopathy 2 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004534772 | SCV004755524 | likely benign | TNNT2-related disorder | 2023-10-17 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |